Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Women exploring GLP-1 therapy often ask whether these medications support or hinder pregnancy plans. Research shows that weight loss from semaglutide and tirzepatide can restore ovulatory function in women with polycystic ovary syndrome (PCOS) and improve metabolic markers tied to conception success. The answer depends on your individual timeline and health profile.
How GLP-1 Medications Affect Female Fertility
GLP-1 receptor agonists work by slowing stomach emptying, reducing appetite signals, and improving blood sugar control. These actions trigger weight loss, which directly impacts hormonal balance in women. Excess body fat produces estrogen and inflammatory markers that disrupt the delicate hormonal environment needed for ovulation. By reducing weight and insulin levels, GLP-1 therapy can restore regular menstrual cycles and improve egg quality markers.
Clinical evidence shows that women with PCOS who achieve 5–10% weight loss experience higher ovulation rates and improved fertility outcomes. Semaglutide-induced weight loss may improve luteal phase length, reduce androgen levels, and normalize follicle-stimulating hormone (FSH) patterns. These changes create conditions more favorable for natural conception or assisted reproductive technology (ART) success.
Semaglutide and Pregnancy Planning: Timing Considerations
If you are actively trying to conceive, the timing of GLP-1 therapy matters. Most fertility specialists recommend stabilizing your weight loss and discontinuing semaglutide 2–3 months before attempting pregnancy. This allows your body to metabolize the medication fully and lets your appetite and satiety signals return to baseline. During this window, your weight typically stabilizes if diet and exercise habits have been established.
PlexusDx semaglutide therapy begins at $149 per month, making it accessible for women who want to improve metabolic health before conception attempts. If your fertility plan includes a timeline, discuss this with your PlexusDx provider during your initial consultation so dosing and discontinuation can align with your reproductive goals.
GLP-1 Safety in Early Pregnancy and Lactation
Semaglutide has not been studied extensively in pregnant women, so current medical guidelines recommend stopping GLP-1 therapy once pregnancy is confirmed. The FDA classifies semaglutide as Category C for pregnancy, meaning animal studies show potential risk but human data is limited. Because appetite suppression and rapid weight loss during pregnancy can compromise fetal development and nutrient delivery, stopping the medication is the standard of care.
GLP-1 medications are also not recommended during breastfeeding, as drug transfer into breast milk is not fully characterized. If you plan to nurse, discontinuing semaglutide before conception ensures a medication-free window for both pregnancy and lactation. After weaning, you can resume GLP-1 therapy if weight management remains a goal.
Precision Peptide Genetic Testing for Fertility and Metabolism
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to identify how your unique genetic variants affect weight regulation, appetite, and metabolic hormones. Key variants like FTO rs9939609 and MC4R rs17782313 influence how strongly you respond to GLP-1 therapy and how quickly you may see fertility-related improvements. Understanding your peptide pathway predispositions helps your PlexusDx provider optimize therapy before your pregnancy timeline.
Women with specific genetic profiles may experience faster weight loss and hormonal normalization on semaglutide, potentially shortening the time needed to restore ovulation. Your genetic insights inform whether standard or microdose protocols may work best for your fertility goals, and help predict how your body will regulate appetite and energy during the conception window.
Managing Weight Loss Therapy While Trying to Conceive
If you are already on semaglutide and planning pregnancy within 6–12 months, work with your PlexusDx provider to create a transition strategy. This may include stabilizing your dose, achieving target weight loss, and then tapering off gradually. Many women find that the lifestyle habits built during GLP-1 therapy—structured eating, regular movement, stress management—sustain weight loss even after the medication is discontinued.
Combining semaglutide therapy with fertility-aware nutrition and preconception counseling maximizes your chances of success. PlexusDx compounds semaglutide through licensed 503A pharmacies and serves all 50 states without requiring insurance or membership fees. HSA and FSA plans cover compounded semaglutide, reducing out-of-pocket costs during your fertility preparation phase.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide while trying to get pregnant?
No—most fertility specialists recommend stopping semaglutide 2–3 months before attempting pregnancy to allow full metabolism of the drug and return of normal appetite signals. However, using semaglutide to achieve weight loss *before* trying to conceive can significantly improve your fertility odds, especially if you have PCOS or insulin resistance.
Does weight loss from GLP-1 therapy improve PCOS and ovulation?
Yes. Studies show that 5–10% weight loss via GLP-1 therapy restores ovulatory cycles in women with PCOS by lowering insulin and androgen levels. By reducing inflammation and normalizing follicle-stimulating hormone patterns, semaglutide creates an environment more favorable for egg development and natural conception.
What is PlexusDx semaglutide pricing and how does it work with my fertility timeline?
PlexusDx compounded semaglutide starts at $149 per month and is available without insurance or membership fees in all 50 states. Your dose may increase, but your price stays flat. If you have a specific pregnancy timeline, discuss it with your PlexusDx provider at consultation so treatment can be coordinated with your fertility goals.
Is semaglutide safe if I get pregnant while taking it?
Semaglutide is classified as Category C for pregnancy, meaning animal studies show potential risk and human data is limited. Current medical guidelines recommend stopping GLP-1 therapy immediately upon pregnancy confirmation because appetite suppression and weight loss during pregnancy can affect fetal development and nutrient delivery.
Can the Precision Peptide Genetic Test help predict my fertility response to semaglutide?
Yes. PlexusDx Precision Peptide Genetic Testing ($99 add-on) maps variants like FTO rs9939609 and MC4R rs17782313 that influence your metabolic response and speed of weight loss. Faster weight loss on semaglutide may mean quicker restoration of ovulatory cycles, helping you reach your pregnancy timeline sooner.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Intermittent Fast on GLP-1 Medications?
Is It Possible to Keep Weight Off After Semaglutide?